This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing the 4th edition of their workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 24-28, 2023. The last date to apply for the workshop is March 25, 2023.
We are pleased to inform you that the Inter-University Centre for IPR Studies (IUCIPRS), Cochin University of Science and Technology (CUSAT), and Third World Network are organizing a workshop on ‘Patent Oppositions in the Pharmaceutical Field’ from December 4- 8, 2022 in Kochi, Kerala. Below is the link to the application form.
Earlier this year, IPKat reported on the EPO's advertised workshop on description amendments ( IPKat ). The stated aim of the workshop, which took place at the end of June, was to provide users with "clarity" on description amendments in view of some recent conflicting decisions on the topic from the Boards of Appeal.
We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing a workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 26-30, 2024. The last date to apply for the workshop is March 24, 2024.
CIPET: Institute of Petrochemicals Technology (IPT) at Patia, Bhubaneswar recently took an initiative for organizing a one-day workshop with the IP leading firm Biswajit Sarkar Advocates and IP Attorneys for inspiring young minds to create inventions and innovations so that those inventions can be later provided with patent protection.
Balaji of the Madras High Court (MHC) delivered two decisions that overturned the Controller’s rejection of patentapplications, siding with the appellants in both cases. Bitter Pill to Swallow: Controller’s Decision Overturned for Kyrorin’s PatentApplication The first one is Kyorin Pharmaceutical Co v.
– Jason) Guided invention sessions not only increase idea submission rates but also transform individuals’ perception of themselves as inventors. By creating a supportive environment and equipping participants with the necessary tools, these sessions pave the way for gender equality in patenting. Here’s how it works.
The Guidelines require that, when amending or adapting the description in line with the claims, the applicant must either delete subject matter not covered by the claims or explicitly state in the description that such subject matter is not part of the invention ( F-IV, 4.3 ). for inter alia lack of inventive step ( Article 56 EPC ).
Description amendments refresh The recent controversy over description amendments began with a significant tightening in the 2021 EPO Guidelines for Examination of the requirement for applicants to amend the description of a patentapplication in line with the allowed claims ( IPKat ).
In yet another order dealing with unreasoned rejections of a patentapplication, the Delhi High Court comes down heavily on the Indian Patent Office. Praharsh and Swaraj write about this order, underscoring the role played by well-reasoned orders in the appeals before the high court and patent bargain.
Delhi High Court on Non-filing of Written Submission to Delay PatentApplication Process. The Controller of Patents where it rebuked the Plaintiff for not filing written submissions in time and thereby delaying the patentapplication process. Course on Access to Medicines, TRIPS and Patents [Kochi, December 10-14].
Introduction to Intellectual Property Rights Understanding the role of a Patent Agent including the qualifications, eligibility criteria Patents and Patentability Criteria Processing of Indian PatentApplicationPatent Drafting Exercise-related to Patent drafting Practice responding to FERs, Amendment of application, and specification Concept of unity (..)
Board of Appeal finds no legal basis for the requirement to amend the description in line with the claims (T1989/18) (26 Dec 2021) Can amending the description to summarize the prior art add matter to the patentapplication as filed? (T Whilst this year has seen some truly remarkable advances in machine learning technology (e.g.
Intellectual Property Rights (“IPR”) law empowers such techno-entrepreneurs to protect their ideas and inventions from misappropriation and encroachment by others, and thereby, enables them to unlock the true potential value of their intellectual property.
Article 69 EPC states that " the extent of the protection conferred by a European patent or a European patentapplication shall be determined by the claims. Nevertheless, the description and drawings shall be used to interpret the claims ". even if that ground has not been invoked by the opponent ".
Introduction A “patent” is a right granted by a state to an inventor for a fixed period i.e., 20 years in India in exchange for the disclosure of the invention. The fundamental patentability criteria are universal namely: novelty, inventive step, non-obviousness and industrial applicability.
Madras High Court Revokes Omega Ecotech’s Patent The Madras High Court on March 28, 2024 revoked Omega Ecotech’s Patent on a multistage bio composting kit and method of composting. The invention had a product claim and method claim. The Court also said that the use of chimneys in the invention is a mere workshop modification.
Reform in Law However, while the patentapplication numbers are on the rise, the Industry has expressed concerns over the patent prosecution and examination regime in India. When mentioned in the recently-held budget session, the IT and Telecom Minister Ashwini Vaishnaw acknowledged the ethical concerns and risks around AI.
Over to Henry: "One could not help but feel sorry for the European Patent (UK) 2 373 755 (‘the Patent’), owned by company 3M. On the second point the Judge started by considering whether the skilled person would have any motivation to conduct workshop modifications to Rowenhorst (para 143). in some embodiments.
The Indian Patent Office has revoked the Patent No. 281489 (Application No. The patent was revoked for lacking obviousness/inventive step, not being a patentableinvention under section 3(d) and failure to disclose requisite information under section 8 of the Patents Act.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content